Molecular Health has joined with GATC Biotech to obtain laboratory information management systems, training, and protocols to support MolecularHealth’s oncology testing and treatment decision support platform.
Read More
The National Cancer Institute has awarded Insight Genetics a $1.5 million Phase II continuation of its SBIR contract for developing a companion diagnostic to assess patient resistance to therapies for non-small cell lung cancer.
Read More
Trovagene and US Oncology Research have joined forces to examine the utility of quantitative urine-based KRAS mutation detection and monitoring in pancreatic cancer patients.
Read MoreThe American Congress of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have jointly issued new guidelines recommending the use of chromosomal microarray analysis in pregnancies with fetal abnormalities.
Read More
Editor-in-Chief Steve Halasey discusses next-generation sequencing with Gregory Heath, senior vice president and general manager for diagnostics at Illumina.
Read More